Texas

Substance Use Treatment for Sale — Texas

American HealthCare Capital is pleased to introduce an Addiction Treatment Center located in a premier Texas location. Based in one of the fastest-growing markets in the US, the company is well-connected to the largest residential treatment providers. They serve patients based all over the United States due to their clinical expertise in treating process addictions. The center was recently licensed and accredited, and they are at the forefront and cutting edge of the industry. The business continues to see monthly increases, and the company has booked new insurance contracts with some of the largest providers. They are currently having a very strong year and experiencing their best growth yet due to an increased volume of telehealth clients and an uptick in demand for mental health services. Based on results through October, in 2020 they are projected to gross at least $1.9 million with an adjusted EBITDA of $730,000. The asking price for this opportunity is $3 million.
Asking price
$3,000,000
Annual revenue
$1,900,000
Type
Substance Use Treatment
Location
Texas
Listing verified
2026-10-09

Listing broker

This mental health practice is represented by American HealthCare Capital (PRIME exits). Full identity and financials come directly from the listing broker, typically after a confidentiality agreement.

View this listing on the broker's site

More mental health practices for sale in Texas

  • Behavioral Health Practice

    Texas

    PRIME exits and American Healthcare Capital are pleased to introduce the largest provider of medical services for private-sector behavioral healthcare hospitals in Texas. The company’s team of family practice doctors, physician assistants, and nurse practitioners provide state-mandated history and physical assessments and medical follow-up care for 100% of patients in several behavioral health hospitals located in major metropolitan areas of Texas.The company treats patients from a wide range of cultural and socioeconomic backgrounds and their practice is committed to providing the highest level of services to patients struggling with or in recovery from addiction or other psychiatric disorders. The practice has earned nationwide recognition in the medical and mental health treatment fields.The practice is centrally managed from a single office, and all employees perform their job functions remotely. The company is also highly efficient in billing and collections and has existing insurance contracts with all major providers in the state of Texas, both in managed Medicare/Medicaid and private insurance. The practice averages 8,500 patient events per month. All referrals come through patients admitted to contracted hospitals.

    Asking price
    $20,000,000
    Annual revenue
    $7,800,000

    Listed by American HealthCare Capital (PRIME exits)

  • Behavioral Health Practice

    Texas

    In 2022, total gross revenue was $3,731,498 with an adjusted EBITDA of $1,359, 847. In 2023, the company’s gross revenue was $4,424,056 with an adjusted EBITDA of $1,281,057. The company is on track to reach $6 million in gross revenue in 2024 with an adjusted EBITDA of $1,955,373. They are currently in talks with a major hospital to secure a contract that is expected to increase EBITDA by 15 – 20%. Beyond this, there are ample opportunities for additional growth, both within their existing customer base, additional vertical markets via telemedicine, and through expansion to new geographies.

    Annual revenue
    $6,000,000

    Listed by American HealthCare Capital (PRIME exits)

  • ABA / Autism Therapy

    Texas

    American HealthCare Capital is pleased to introduce a licensed ABA Therapy company for sale in Northeast Texas. The company has been in business since 2016 and has developed a reputation as one of the premier providers of in-home and center-based therapy for autism clients in the region. The company primarily treats children 14 and younger, working with each family to create individualized goals and behavior intervention plans that are specific to each patient’s needs. Additionally, they provide care for adolescents with special needs, including a wide range of learning, social, and emotional disabilities. The ABA company for sale is in-network with some of the largest providers and has a payer mix of roughly 90% in-network insurance and 10% private pay. Although they were initially impacted by the COVID-19 pandemic, the business quickly recovered because of the company’s ability to adapt to a telehealth model, allowing them to continue seeing clients when in-person treatment was not an option. In 2019, the company generated over $1 million in gross revenues. In 2020, despite the pandemic, they are on track to generate $1.8 million with an adjusted EBITDA of $310,000 (17%). However, in Q3 (July – September), the company experienced a surge in demand and a dramatic rise in revenue and EBITDA, with average monthly revenues of $195,000 and an average monthly EBITDA of $47,400 (24%). Using Q3 results, their projected annual run rate through Q2 2021 is $2.3 million with approximately $600,000 in adjusted EBITDA. All employees are expected to stay on under new ownership and management is in place to take over the sellers’ responsibilities. The seller is also available to assist during a short transition as needed. The asking price for this ABA Therapy company for sale in Texas is $2.5 million.

    Asking price
    $2,500,000
    Annual revenue
    $2,400,000

    Listed by American HealthCare Capital (PRIME exits)